ÂÜÀòÂÒÂ×

Sabit Delic has extensive work experience in the field of scientific research and clinical trials. Sabit is currently serving as the Head of Clinical Trials and QM at MLL Münchner Leukämielabor, a position they have held since July 2022. Prior to this, they worked as a Senior Scientist in Business Development at the same company from October 2020 to June 2022.

Before joining MLL Münchner Leukämielabor, Sabit worked at Diaceutics PLC, where they held the role of Scientific Senior Director from July 2019 to October 2020 and Scientific Director from October 2017 to June 2019.

Their previous experience includes working as a Scientist at Bioscientia from October 2016 to May 2017, and as a Scientist at MLL Münchner Leukämielabor from September 2013 to September 2016.

Sabit's career also includes postdoctoral research positions at the Institute of Neuropathology, University Hospital Regensburg, Germany from July 2011 to August 2013, and at the Institute of Neuropathology, University Hospital Duesseldorf, Germany from July 2008 to June 2011.

Sabit Delic pursued their education in the field of biology, specializing in molecular biology. Sabit received their Master of Science degree from Johannes Gutenberg University Mainz, Germany, between the years 1999 and 2004. Following this, they went on to complete their PhD (Dr. rer. nat) at Technical University of Munich, from 2004 to 2008.